SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 60 filers reported holding SPERO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | -100.0% | 14 | -100.0% | 0.00% | – |
| Q4 2019 | $308,000 | -9.4% | 32,000 | 0.0% | 0.00% | – |
| Q3 2019 | $340,000 | -7.6% | 32,000 | 0.0% | 0.00% | – |
| Q2 2019 | $368,000 | -10.2% | 32,000 | 0.0% | 0.00% | – |
| Q1 2019 | $410,000 | +318.4% | 32,000 | +102.5% | 0.00% | – |
| Q4 2018 | $98,000 | -7.5% | 15,800 | +58.0% | 0.00% | – |
| Q3 2018 | $106,000 | -27.4% | 10,000 | 0.0% | 0.00% | – |
| Q2 2018 | $146,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $14,596,000 | 24.02% |
| Aquilo Capital Management, LLC | 1,154,356 | $12,236,000 | 8.62% |
| VHCP Management II, LLC | 474,015 | $5,025,000 | 1.92% |
| AWM Investment Company, Inc. | 598,315 | $6,342,000 | 1.35% |
| BVF INC/IL | 939,704 | $9,961,000 | 1.05% |
| Novo Holdings A/S | 465,983 | $4,939,000 | 0.85% |
| Alphabet Inc. | 1,112,473 | $11,792,000 | 0.35% |
| Artal Group S.A. | 540,000 | $5,724,000 | 0.23% |
| Rock Springs Capital Management LP | 525,000 | $5,565,000 | 0.22% |
| DAFNA Capital Management LLC | 39,395 | $418,000 | 0.16% |